Sec. 1. 17-A MRSA §701, sub-§4, as amended by PL 1981, c. 436, §1, is further amended to read:

4. "Written instrument" includes any token, coin, stamp, seal, badge, trademark, credit card, absentee ballot application, absentee ballot envelope, medical drug prescription form, other evidence or symbol of value, right, privilege or identification, and any paper, document or other written instrument containing written or printed matter or its equivalent;

Sec. 2. 17-A MRSA §1102, sub-§1, ¶I, as amended by PL 1995, c. 499, §2 and affected by §5, is further amended to read:

I. Unless listed or described in another schedule, all narcotic drugs, including, but not limited to, the following narcotic drugs or their salts, isomers or salts of isomers: heroin (diacetylmorphine), methadone, methadone hydrochloride, levo-alpha-acetyl-methadol, or LAAM, pethidine, morphine, oxycodone, hydrocodone, hydromorphone, fentanyl and opium. As used in this chapter, "heroin" means any compound, mixture or preparation containing heroin;

Sec. 3. 17-A MRSA §1102, sub-§2, ¶D, as enacted by PL 1975, c. 499, §1, is repealed.

Sec. 4. 17-A MRSA §1103, sub-§3, ¶D, as amended by PL 1999, c. 422, §2, is further amended to read:

D. Lysergic acid diethylamide in any of the following quantities, states or concentrations:

(1) Any compound, mixture, substance or solution in a liquid state that contains a detectable quantity of lysergic acid diethylamide;

(2) Fifty or more squares, stamps, tablets or units of any compound, mixture or substance containing a detectable quantity of lysergic acid diethylamide; or

(3) Any quantity of any compound, mixture or substance that, in the aggregate, contains 2,500 micrograms or more of lysergic acid diethylamide; or

Sec. 5. 17-A MRSA §1103, sub-§3, ¶E, as enacted by PL 1999, c. 422, §3, is amended to read:

E. Fourteen grams or more of methamphetamine.;